抗炎症治療薬の世界市場2023年-2027年

◆英語タイトル:Global Anti-inflammatory Therapeutics Market 2023-2027

Technavioが発行した調査報告書(IRTNTR41324-22)◆商品コード:IRTNTR41324-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年12月6日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:世界
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の市場調査レポートでは、世界の抗炎症治療薬市場が2023年から2027年の間に393.2億ドルへ成長し、予測期間中にCAGR 6.7%拡大すると見られています。当調査レポートでは、抗炎症治療薬の世界市場を広く調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(RA(関節リウマチ)、乾癬、MS(多発性硬化症))分析、ドラッグクラス別(抗炎症性生物製剤、副腎皮質ステロイド、非ステロイド性抗炎症薬)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、イギリス、カナダ、中国)分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。また、当レポートに掲載されている企業情報にはAbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Ltd., Eli Lilly and Co., F. Hoffmann-La Roche Ltd, Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson, Lupin Ltd., Mylan N.V, Novartis AGなどが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の抗炎症治療薬市場規模:用途別
- RA(関節リウマチにおける市場規模
- 乾癬における市場規模
- MS(多発性硬化症)における市場規模
・世界の抗炎症治療薬市場規模:ドラッグクラス別
- 抗炎症性生物製剤における市場規模
- 副腎皮質ステロイドにおける市場規模
- 非ステロイド性抗炎症薬における市場規模
・顧客状況
・世界の抗炎症治療薬市場規模:地域別
- 北米の抗炎症治療薬市場
- ヨーロッパの抗炎症治療薬市場
- アジアの抗炎症治療薬市場
- その他地域の抗炎症治療薬市場
- アメリカの抗炎症治療薬市場
- ドイツの抗炎症治療薬市場
- イギリスの抗炎症治療薬市場
- カナダの抗炎症治療薬市場
- 中国の抗炎症治療薬市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの主要なパラメーターの分析から、複数のソースからのデータを研究、統合、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要インフルエンサーを特定することにより、市場の様々な側面を提供します。提示される情報は包括的​​で信頼性が高く、一次・二次の広範囲な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するために、完璧な競争環境と定性的・定量的調査手法を用いた詳細なベンダー選定方法と分析を提供します。

Global Anti-inflammatory Therapeutics Market 2023-2027
Technavio has been monitoring the anti-inflammatory therapeutics market and it is poised to grow by $39.32 bn during 2023-2027, accelerating at a CAGR of 6.7% during the forecast period. Our report on the anti-inflammatory therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in off-label use, unmet needs for safer biologics for RA, and the availability of improved diagnostic modalities.

Technavio’s anti-inflammatory therapeutics market is segmented as below:
By Application
• RA
• Psoriasis
• MS

By Drug Class
• Anti-inflammatory biologicals
• Corticosteroids
• NSAIDs

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of novel anti-inflammatory drugs as one of the prime reasons driving the anti-inflammatory therapeutics market growth during the next few years. Also, the use of gene therapy for RA treatment and market dominance by TNF-alpha inhibitors will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the anti-inflammatory therapeutics market covers the following areas:
• Anti-inflammatory therapeutics market sizing
• Anti-inflammatory therapeutics market forecast
• Anti-inflammatory therapeutics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-inflammatory therapeutics market vendors that include AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Ltd., Eli Lilly and Co., F. Hoffmann-La Roche Ltd, Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson, Lupin Ltd., Mylan N.V, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., and Sanofi SA. Also, the anti-inflammatory therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary.
Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global anti-inflammatory therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global anti-inflammatory therapeutics market 2017 – 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
o 4.3 Drug class Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Drug class Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 RA – Market size and forecast 2022-2027
o Exhibit 34: Chart on RA – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on RA – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on RA – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on RA – Year-over-year growth 2022-2027 (%)
o 6.4 Psoriasis – Market size and forecast 2022-2027
o Exhibit 38: Chart on Psoriasis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Psoriasis – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Psoriasis – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Psoriasis – Year-over-year growth 2022-2027 (%)
o 6.5 MS – Market size and forecast 2022-2027
o Exhibit 42: Chart on MS – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on MS – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on MS – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on MS – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ billion)
• 7 Market Segmentation by Drug Class
o 7.1 Market segments
o Exhibit 47: Chart on Drug Class – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Drug Class – Market share 2022-2027 (%)
o 7.2 Comparison by Drug Class
o Exhibit 49: Chart on Comparison by Drug Class
o Exhibit 50: Data Table on Comparison by Drug Class
o 7.3 Anti-inflammatory biologicals – Market size and forecast 2022-2027
o Exhibit 51: Chart on Anti-inflammatory biologicals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Anti-inflammatory biologicals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Anti-inflammatory biologicals – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Anti-inflammatory biologicals – Year-over-year growth 2022-2027 (%)
o 7.4 Corticosteroids – Market size and forecast 2022-2027
o Exhibit 55: Chart on Corticosteroids – Market size and forecast 2022-2027 ($ billion)
o Exhibit 56: Data Table on Corticosteroids – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Chart on Corticosteroids – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Corticosteroids – Year-over-year growth 2022-2027 (%)
o 7.5 NSAIDs – Market size and forecast 2022-2027
o Exhibit 59: Chart on NSAIDs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 60: Data Table on NSAIDs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Chart on NSAIDs – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on NSAIDs – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Drug Class
o Exhibit 63: Market opportunity by Drug Class ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 97: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 101: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 102: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 103: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 105: Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 112: AbbVie Inc. – Overview
o Exhibit 113: AbbVie Inc. – Product / Service
o Exhibit 114: AbbVie Inc. – Key news
o Exhibit 115: AbbVie Inc. – Key offerings
o 12.4 Alvogen Iceland ehf
o Exhibit 116: Alvogen Iceland ehf – Overview
o Exhibit 117: Alvogen Iceland ehf – Product / Service
o Exhibit 118: Alvogen Iceland ehf – Key offerings
o 12.5 Amgen Inc.
o Exhibit 119: Amgen Inc. – Overview
o Exhibit 120: Amgen Inc. – Product / Service
o Exhibit 121: Amgen Inc. – Key offerings
o 12.6 Amneal Pharmaceuticals Inc.
o Exhibit 122: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 123: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 124: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 125: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 126: Amneal Pharmaceuticals Inc. – Segment focus
o 12.7 Bayer AG
o Exhibit 127: Bayer AG – Overview
o Exhibit 128: Bayer AG – Business segments
o Exhibit 129: Bayer AG – Key news
o Exhibit 130: Bayer AG – Key offerings
o Exhibit 131: Bayer AG – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 132: Bristol Myers Squibb Co. – Overview
o Exhibit 133: Bristol Myers Squibb Co. – Product / Service
o Exhibit 134: Bristol Myers Squibb Co. – Key news
o Exhibit 135: Bristol Myers Squibb Co. – Key offerings
o 12.9 Eli Lilly and Co.
o Exhibit 136: Eli Lilly and Co. – Overview
o Exhibit 137: Eli Lilly and Co. – Product / Service
o Exhibit 138: Eli Lilly and Co. – Key offerings
o 12.10 F. Hoffmann-La Roche Ltd
o Exhibit 139: F. Hoffmann-La Roche Ltd – Overview
o Exhibit 140: F. Hoffmann-La Roche Ltd – Product / Service
o Exhibit 141: F. Hoffmann-La Roche Ltd – Key offerings
o 12.11 Ferring BV
o Exhibit 142: Ferring BV – Overview
o Exhibit 143: Ferring BV – Product / Service
o Exhibit 144: Ferring BV – Key offerings
o 12.12 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc – Overview
o Exhibit 146: GlaxoSmithKline Plc – Business segments
o Exhibit 147: GlaxoSmithKline Plc – Key offerings
o Exhibit 148: GlaxoSmithKline Plc – Segment focus
o 12.13 Johnson and Johnson
o Exhibit 149: Johnson and Johnson – Overview
o Exhibit 150: Johnson and Johnson – Business segments
o Exhibit 151: Johnson and Johnson – Key news
o Exhibit 152: Johnson and Johnson – Key offerings
o Exhibit 153: Johnson and Johnson – Segment focus
o 12.14 Mylan N.V
o Exhibit 154: Mylan N.V – Overview
o Exhibit 155: Mylan N.V – Product / Service
o Exhibit 156: Mylan N.V – Key offerings
o 12.15 Novartis AG
o Exhibit 157: Novartis AG – Overview
o Exhibit 158: Novartis AG – Business segments
o Exhibit 159: Novartis AG – Key offerings
o Exhibit 160: Novartis AG – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 161: Pfizer Inc. – Overview
o Exhibit 162: Pfizer Inc. – Product / Service
o Exhibit 163: Pfizer Inc. – Key news
o Exhibit 164: Pfizer Inc. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 165: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 166: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 167: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 168: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 169: Teva Pharmaceutical Industries Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global anti-inflammatory therapeutics market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Drug class Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on RA – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on RA – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on RA – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on RA – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Psoriasis – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Psoriasis – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Psoriasis – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Psoriasis – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on MS – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on MS – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on MS – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on MS – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Chart on Drug Class – Market share 2022-2027 (%)
Exhibits48: Data Table on Drug Class – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Drug Class
Exhibits50: Data Table on Comparison by Drug Class
Exhibits51: Chart on Anti-inflammatory biologicals – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Anti-inflammatory biologicals – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Anti-inflammatory biologicals – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Anti-inflammatory biologicals – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Corticosteroids – Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Corticosteroids – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Corticosteroids – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Corticosteroids – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on NSAIDs – Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on NSAIDs – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on NSAIDs – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on NSAIDs – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Drug Class ($ billion)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ billion)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: AbbVie Inc. – Overview
Exhibits113: AbbVie Inc. – Product / Service
Exhibits114: AbbVie Inc. – Key news
Exhibits115: AbbVie Inc. – Key offerings
Exhibits116: Alvogen Iceland ehf – Overview
Exhibits117: Alvogen Iceland ehf – Product / Service
Exhibits118: Alvogen Iceland ehf – Key offerings
Exhibits119: Amgen Inc. – Overview
Exhibits120: Amgen Inc. – Product / Service
Exhibits121: Amgen Inc. – Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. – Overview
Exhibits123: Amneal Pharmaceuticals Inc. – Business segments
Exhibits124: Amneal Pharmaceuticals Inc. – Key news
Exhibits125: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits126: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits127: Bayer AG – Overview
Exhibits128: Bayer AG – Business segments
Exhibits129: Bayer AG – Key news
Exhibits130: Bayer AG – Key offerings
Exhibits131: Bayer AG – Segment focus
Exhibits132: Bristol Myers Squibb Co. – Overview
Exhibits133: Bristol Myers Squibb Co. – Product / Service
Exhibits134: Bristol Myers Squibb Co. – Key news
Exhibits135: Bristol Myers Squibb Co. – Key offerings
Exhibits136: Eli Lilly and Co. – Overview
Exhibits137: Eli Lilly and Co. – Product / Service
Exhibits138: Eli Lilly and Co. – Key offerings
Exhibits139: F. Hoffmann-La Roche Ltd – Overview
Exhibits140: F. Hoffmann-La Roche Ltd – Product / Service
Exhibits141: F. Hoffmann-La Roche Ltd – Key offerings
Exhibits142: Ferring BV – Overview
Exhibits143: Ferring BV – Product / Service
Exhibits144: Ferring BV – Key offerings
Exhibits145: GlaxoSmithKline Plc – Overview
Exhibits146: GlaxoSmithKline Plc – Business segments
Exhibits147: GlaxoSmithKline Plc – Key offerings
Exhibits148: GlaxoSmithKline Plc – Segment focus
Exhibits149: Johnson and Johnson – Overview
Exhibits150: Johnson and Johnson – Business segments
Exhibits151: Johnson and Johnson – Key news
Exhibits152: Johnson and Johnson – Key offerings
Exhibits153: Johnson and Johnson – Segment focus
Exhibits154: Mylan N.V – Overview
Exhibits155: Mylan N.V – Product / Service
Exhibits156: Mylan N.V – Key offerings
Exhibits157: Novartis AG – Overview
Exhibits158: Novartis AG – Business segments
Exhibits159: Novartis AG – Key offerings
Exhibits160: Novartis AG – Segment focus
Exhibits161: Pfizer Inc. – Overview
Exhibits162: Pfizer Inc. – Product / Service
Exhibits163: Pfizer Inc. – Key news
Exhibits164: Pfizer Inc. – Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits166: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits167: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits168: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits169: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗炎症治療薬の世界市場2023年-2027年(Global Anti-inflammatory Therapeutics Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆